{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:14:34Z","timestamp":1783394074403,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322007"],"award-info":[{"award-number":["82322007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300417"],"award-info":[{"award-number":["82300417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170377"],"award-info":[{"award-number":["82170377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460073"],"award-info":[{"award-number":["82460073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2022YFC2503401"],"award-info":[{"award-number":["2022YFC2503401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) markedly accelerates calcific aortic valve disease (CAVD), yet the underlying mechanisms and therapeutic targets remain poorly defined. Here, we integrate population-scale analyses, single-cell transcriptomics, genetic inference and functional experiments to identify a central role for Sirtuin 1 (SIRT1) in CKD-associated aortic valve calcification. Analysis of UK Biobank data linked CKD to accelerated ageing and increased aortic stenosis risk. Single-cell RNA sequencing of human aortic valves identified SIRT1 downregulation and NLRP3 pathway activation specifically in myofibroblast valve interstitial cells (VICs), coupled with enhanced senescence and osteogenic programmes. Consistently, genetic analyses, including eQTL-based Mendelian randomization, supported an inverse association between SIRT1 expression and CAVD risk. SIRT1 deficiency was associated with enhanced glycolysis, increased NF-\u03baB activation and NLRP3 inflammasome signalling, accompanied by augmented osteogenic differentiation and calcification of VICs. Pharmacological or genetic inhibition of NLRP3 attenuated valve calcification in vivo, establishing the SIRT1-NF-\u03baB-NLRP3 axis as a critical pathway linking CKD to CAVD. Finally, screening of anti-diabetic compounds identified semaglutide as a potent modulator that restores the SIRT1\/NLRP3 balance and alleviates calcification in vitro and in vivo. These findings define a metabolic-inflammatory coupling mechanism underlying CKD-induced CAVD and highlight SIRT1 as a therapeutic target. Modulation of the SIRT1-NLRP3 axis, particularly by semaglutide, may represent a promising strategy for preventing valve calcification.<\/jats:p>","DOI":"10.1186\/s43556-026-00488-3","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:28:42Z","timestamp":1783391322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sirtuin 1 deficiency mediates chronic kidney disease-induced inflammaging cardiovascular calcification"],"prefix":"10.1186","volume":"7","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengning","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqi","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhejun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"10523","key":"488_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0140-6736(25)01942-7","volume":"407","author":"WG Herrington","year":"2026","unstructured":"Herrington WG, Judge PK, Grams ME, Wanner C. Chronic kidney disease. Lancet. 2026;407(10523):90\u2013104. https:\/\/doi.org\/10.1016\/S0140-6736(25)01942-7.","journal-title":"Lancet"},{"issue":"6","key":"488_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nefro.2016.05.021","volume":"36","author":"J Bover","year":"2016","unstructured":"Bover J, G\u00f3rriz JL, Ure\u00f1a-Torres P, Lloret MJ, Ruiz-Garc\u00eda C, daSilva I, et al. Detection of cardiovascular calcifications: Is it a useful tool for nephrologists? Nefrologia. 2016;36(6):587\u201396. https:\/\/doi.org\/10.1016\/j.nefro.2016.05.021.","journal-title":"Nefrologia"},{"issue":"8","key":"488_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41581-024-00837-x","volume":"20","author":"H Noels","year":"2024","unstructured":"Noels H, Jankowski V, Schunk SJ, Vanholder R, Kalim S, Jankowski J. Post-translational modifications in kidney diseases and associated cardiovascular risk. Nat Rev Nephrol. 2024;20(8):495\u2013512. https:\/\/doi.org\/10.1038\/s41581-024-00837-x.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"488_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","volume":"107","author":"P Conference","year":"2025","unstructured":"Conference P, Ketteler M, Evenepoel P, Holden RM, Isakova T, J\u00f8rgensen HS, et al. Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2025;107(3):405\u201323. https:\/\/doi.org\/10.1016\/j.kint.2024.11.013.","journal-title":"Kidney Int"},{"issue":"23","key":"488_CR5","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1001\/jama.2024.16477","volume":"332","author":"CM Otto","year":"2024","unstructured":"Otto CM, Newby DE, Hillis GS. Calcific aortic stenosis: a review. JAMA. 2024;332(23):2014\u201326. https:\/\/doi.org\/10.1001\/jama.2024.16477.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"488_CR6","doi-asserted-by":"publisher","first-page":"i27","DOI":"10.1093\/ckj\/sfae421","volume":"18","author":"L H\u00e9naut","year":"2025","unstructured":"H\u00e9naut L, Candellier A, Huish S, Issa N, Sinha S, Massy ZA. Valvular calcification in chronic kidney disease: new insights from recent clinical and preclinical studies. Clin Kidney J. 2025;18(Suppl 1):i27\u201345. https:\/\/doi.org\/10.1093\/ckj\/sfae421.","journal-title":"Clin Kidney J"},{"issue":"12","key":"488_CR7","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/ndt\/gft310","volume":"28","author":"M Rattazzi","year":"2013","unstructured":"Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant. 2013;28(12):2968\u201376. https:\/\/doi.org\/10.1093\/ndt\/gft310.","journal-title":"Nephrol Dial Transplant"},{"issue":"23","key":"488_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252313096","volume":"25","author":"C Siracusa","year":"2024","unstructured":"Siracusa C, Carabetta N, Morano MB, Manica M, Strangio A, Sabatino J, et al. Understanding vascular calcification in chronic kidney disease: pathogenesis and therapeutic implications. Int J Mol Sci. 2024;25(23):13096. https:\/\/doi.org\/10.3390\/ijms252313096.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"488_CR9","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.18632\/aging.102046","volume":"11","author":"C Viegas","year":"2019","unstructured":"Viegas C, Ara\u00fajo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts. Aging (Albany NY). 2019;11(12):4274\u201399. https:\/\/doi.org\/10.18632\/aging.102046.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"488_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2024.2417742","volume":"46","author":"W Pan","year":"2024","unstructured":"Pan W, Zhou L, Han R, Du X, Chen W, Jiang T. Causal associations between kidney function and aortic valve stenosis: a bidirectional Mendelian randomization analysis. Ren Fail. 2024;46(2):2417742. https:\/\/doi.org\/10.1080\/0886022x.2024.2417742.","journal-title":"Ren Fail"},{"issue":"1","key":"488_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/eurheartj\/ehu095","volume":"36","author":"MX Miranda","year":"2015","unstructured":"Miranda MX, van Tits LJ, Lohmann C, Arsiwala T, Winnik S, Tailleux A, et al. The Sirt1 activator SRT3025 provides atheroprotection in Apoe-\/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression. Eur Heart J. 2015;36(1):51\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehu095.","journal-title":"Eur Heart J"},{"issue":"13","key":"488_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134655","volume":"21","author":"D Feng","year":"2020","unstructured":"Feng D, Xu D, Murakoshi N, Tajiri K, Qin R, Yonebayashi S, et al. Nicotinamide phosphoribosyltransferase (Nampt)\/nicotinamide adenine dinucleotide (NAD) axis suppresses atrial fibrillation by modulating the calcium handling pathway. Int J Mol Sci. 2020;21(13):4655. https:\/\/doi.org\/10.3390\/ijms21134655.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"488_CR13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369\u201380. https:\/\/doi.org\/10.1038\/sj.emboj.7600244.","journal-title":"EMBO J"},{"issue":"11","key":"488_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111495","volume":"17","author":"M Law","year":"2024","unstructured":"Law M, Wang PC, Zhou ZY, Wang Y. From microcirculation to aging-related diseases: a focus on endothelial SIRT1. Pharmaceuticals (Basel). 2024;17(11):1495. https:\/\/doi.org\/10.3390\/ph17111495.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"488_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-21905-7","volume":"15","author":"C Wu","year":"2025","unstructured":"Wu C, Wu Z, Hu L, Tang L, Hu X, Fang C. SIRT1\/PGC-1\u03b1\/Mfn2 pathway regulates mitochondrial homeostasis in VSMC to attenuate aging-related vascular calcification. Sci Rep. 2025;15(1):38045. https:\/\/doi.org\/10.1038\/s41598-025-21905-7.","journal-title":"Sci Rep"},{"issue":"6","key":"488_CR16","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00982-y","volume":"26","author":"X Yu","year":"2024","unstructured":"Yu X, Xu L, Su C, Wang C, Wang Z, Wang Y, et al. Luteolin protects against vascular calcification by modulating SIRT1\/CXCR4 signaling pathway and promoting autophagy. AAPS J. 2024;26(6):111. https:\/\/doi.org\/10.1208\/s12248-024-00982-y.","journal-title":"AAPS J"},{"issue":"1","key":"488_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12661","volume":"69","author":"L Xia","year":"2020","unstructured":"Xia L, Sun C, Zhu H, Zhai M, Zhang L, Jiang L, et al. Melatonin protects against thoracic aortic aneurysm and dissection through SIRT1-dependent regulation of oxidative stress and vascular smooth muscle cell loss. J Pineal Res. 2020;69(1):e12661. https:\/\/doi.org\/10.1111\/jpi.12661.","journal-title":"J Pineal Res"},{"issue":"4","key":"488_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"32","author":"AF McGettrick","year":"2020","unstructured":"McGettrick AF, O\u2019Neill LAJ. The role of HIF in immunity and inflammation. Cell Metab. 2020;32(4):524\u201336. https:\/\/doi.org\/10.1016\/j.cmet.2020.08.002.","journal-title":"Cell Metab"},{"key":"488_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.6","volume":"2","author":"BR Lindman","year":"2016","unstructured":"Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006. https:\/\/doi.org\/10.1038\/nrdp.2016.6.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"488_CR20","first-page":"217","volume":"20","author":"P Ure\u00f1a","year":"1999","unstructured":"Ure\u00f1a P, Malergue MC, Goldfarb B, Prieur P, Gu\u00e9don-Rapoud C, P\u00e9trover M. Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. Nephrologie. 1999;20(4):217\u201325.","journal-title":"Nephrologie"},{"issue":"11","key":"488_CR21","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2015.06.1334","volume":"66","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Guo Y, Samadashvili Z, Blecker S, Xu J, Hannan EL. Revascularization in patients with multivessel coronary artery disease and chronic kidney disease: everolimus-eluting stents versus coronary artery bypass graft surgery. J Am Coll Cardiol. 2015;66(11):1209\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2015.06.1334.","journal-title":"J Am Coll Cardiol"},{"key":"488_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","volume":"75","author":"AA Sauve","year":"2006","unstructured":"Sauve AA, Wolberger C, Schramm VL, Boeke JD. The biochemistry of sirtuins. Annu Rev Biochem. 2006;75:435\u201365. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133500.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"488_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/shk.0000000000001429","volume":"54","author":"LM Smith","year":"2020","unstructured":"Smith LM, Yoza BK, Hoth JJ, McCall CE, Vachharajani V. SIRT1 mediates septic cardiomyopathy in a murine model of polymicrobial sepsis. Shock. 2020;54(1):96\u2013101. https:\/\/doi.org\/10.1097\/shk.0000000000001429.","journal-title":"Shock"},{"issue":"1","key":"488_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/abbs\/gms108","volume":"45","author":"X Li","year":"2013","unstructured":"Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin. 2013;45(1):51\u201360. https:\/\/doi.org\/10.1093\/abbs\/gms108.","journal-title":"Acta Biochim Biophys Sin"},{"key":"488_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8167273","volume":"2016","author":"VT Vachharajani","year":"2016","unstructured":"Vachharajani VT, Liu T, Wang X, Hoth JJ, Yoza BK, McCall CE. Sirtuins link inflammation and metabolism. J Immunol Res. 2016;2016:8167273. https:\/\/doi.org\/10.1155\/2016\/8167273.","journal-title":"J Immunol Res"},{"issue":"9","key":"488_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12091942","volume":"12","author":"H Wu","year":"2024","unstructured":"Wu H, Qiu Z, Wang L, Li W. Renal fibrosis: SIRT1 still of value. Biomedicines. 2024;12(9):1942. https:\/\/doi.org\/10.3390\/biomedicines12091942.","journal-title":"Biomedicines"},{"issue":"1","key":"488_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023;8(1):239. https:\/\/doi.org\/10.1038\/s41392-023-01502-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"488_CR28","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/cvr\/cvae240","volume":"121","author":"JF Aranda","year":"2024","unstructured":"Aranda JF, Ram\u00edrez CM, Mittelbrunn M. Inflammageing, a targetable pathway for preventing cardiovascular diseases. Cardiovasc Res. 2024;121(10):1537\u201350. https:\/\/doi.org\/10.1093\/cvr\/cvae240.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"488_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7(1):402. https:\/\/doi.org\/10.1038\/s41392-022-01257-8.","journal-title":"Signal Transduct Target Ther"},{"key":"488_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00826","volume":"11","author":"M Liu","year":"2020","unstructured":"Liu M, Li F, Huang Y, Zhou T, Chen S, Li G, et al. Caffeic acid phenethyl ester ameliorates calcification by inhibiting activation of the AKT\/NF-\u03baB\/NLRP3 inflammasome pathway in human aortic valve interstitial cells. Front Pharmacol. 2020;11:826. https:\/\/doi.org\/10.3389\/fphar.2020.00826.","journal-title":"Front Pharmacol"},{"key":"488_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.canlet.2017.12.035","volume":"418","author":"Q Yu","year":"2018","unstructured":"Yu Q, Dong L, Li Y, Liu G. SIRT1 and HIF1\u03b1 signaling in metabolism and immune responses. Cancer Lett. 2018;418:20\u20136. https:\/\/doi.org\/10.1016\/j.canlet.2017.12.035.","journal-title":"Cancer Lett"},{"issue":"4","key":"488_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon A, Goldrath AW, Nizet V, Johnson RS. HIF transcription factors, inflammation, and immunity. Immunity. 2014;41(4):518\u201328. https:\/\/doi.org\/10.1016\/j.immuni.2014.09.008.","journal-title":"Immunity"},{"issue":"1","key":"488_CR33","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.18632\/oncotarget.12157","volume":"8","author":"X Ye","year":"2017","unstructured":"Ye X, Li M, Hou T, Gao T, Zhu WG, Yang Y. Sirtuins in glucose and lipid metabolism. Oncotarget. 2017;8(1):1845\u201359. https:\/\/doi.org\/10.18632\/oncotarget.12157.","journal-title":"Oncotarget"},{"issue":"2","key":"488_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-019-0259-8","volume":"20","author":"LB Ivashkiv","year":"2020","unstructured":"Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat Rev Immunol. 2020;20(2):85\u20136. https:\/\/doi.org\/10.1038\/s41577-019-0259-8.","journal-title":"Nat Rev Immunol"},{"issue":"17","key":"488_CR35","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/eurheartj\/ehac037","volume":"43","author":"Z Liu","year":"2022","unstructured":"Liu Z, Dong N, Hui H, Wang Y, Liu F, Xu L, et al. Endothelial cell-derived tetrahydrobiopterin prevents aortic valve calcification. Eur Heart J. 2022;43(17):1652\u201364. https:\/\/doi.org\/10.1093\/eurheartj\/ehac037.","journal-title":"Eur Heart J"},{"key":"488_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01173","volume":"10","author":"AWC Man","year":"2019","unstructured":"Man AWC, Li H, Xia N. The role of Sirtuin1 in regulating endothelial function, arterial remodeling and vascular aging. Front Physiol. 2019;10:1173. https:\/\/doi.org\/10.3389\/fphys.2019.01173.","journal-title":"Front Physiol"},{"issue":"6","key":"488_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.18632\/aging.100162","volume":"2","author":"S Stein","year":"2010","unstructured":"Stein S, Sch\u00e4fer N, Breitenstein A, Besler C, Winnik S, Lohmann C, et al. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-\/- mice. Aging (Albany NY). 2010;2(6):353\u201360. https:\/\/doi.org\/10.18632\/aging.100162.","journal-title":"Aging (Albany NY)"},{"key":"488_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/ehjvshd\/xwag018","author":"L Weiss","year":"2026","unstructured":"Weiss L, Turner ME, Qin Z, B\u00e4ck M, Aikawa E. Molecular mechanisms of aortic stenosis: deciphering the role of cellular metabolism in the pursuit of novel therapeutic targets. Eur Heart J Valv Struct Heart Dis. 2026. https:\/\/doi.org\/10.1093\/ehjvshd\/xwag018.","journal-title":"Eur Heart J Valv Struct Heart Dis"},{"issue":"9","key":"488_CR39","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/circresaha.121.318011","volume":"128","author":"K Driscoll","year":"2021","unstructured":"Driscoll K, Cruz AD, Butcher JT. Inflammatory and biomechanical drivers of endothelial-interstitial interactions in calcific aortic valve disease. Circ Res. 2021;128(9):1344\u201370. https:\/\/doi.org\/10.1161\/circresaha.121.318011.","journal-title":"Circ Res"},{"issue":"8 Pt 1","key":"488_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","volume":"11","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Christensen L, Davies M, et al. Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype. JACC Heart Fail. 2023;11(8 Pt 1):1000\u201310. https:\/\/doi.org\/10.1016\/j.jchf.2023.05.010.","journal-title":"JACC Heart Fail"},{"key":"488_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2024.100340","volume":"36","author":"H Yaribeygi","year":"2024","unstructured":"Yaribeygi H, Maleki M, Jamialahmadi T, Sahebkar A. Anti-inflammatory benefits of semaglutide: state of the art. J Clin Transl Endocrinol. 2024;36:100340. https:\/\/doi.org\/10.1016\/j.jcte.2024.100340.","journal-title":"J Clin Transl Endocrinol"},{"issue":"6","key":"488_CR42","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.5052","volume":"48","author":"L Wang","year":"2021","unstructured":"Wang L, Ding J, Zhu C, Guo B, Yang W, He W, et al. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazole-kindled mice. Int J Mol Med. 2021;48(6):214. https:\/\/doi.org\/10.3892\/ijmm.2021.5052.","journal-title":"Int J Mol Med"},{"issue":"21","key":"488_CR43","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.3390\/jcm13216431","volume":"13","author":"P Karakasis","year":"2024","unstructured":"Karakasis P, Patoulias D, Giannakoulas G, Sagris M, Theofilis P, Fragakis N, et al. Effect of glucagon-like peptide-1 receptor agonism on aortic valve stenosis risk: a Mendelian randomization analysis. J Clin Med. 2024;13(21):6431. https:\/\/doi.org\/10.3390\/jcm13216431.","journal-title":"J Clin Med"},{"issue":"21","key":"488_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218263","volume":"21","author":"M Donato","year":"2020","unstructured":"Donato M, Ferri N, Lupo MG, Faggin E, Rattazzi M. Current evidence and future perspectives on pharmacological treatment of calcific aortic valve stenosis. Int J Mol Sci. 2020;21(21):8263. https:\/\/doi.org\/10.3390\/ijms21218263.","journal-title":"Int J Mol Sci"},{"key":"488_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1583267","volume":"16","author":"F Liu","year":"2025","unstructured":"Liu F, Cai H. Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy. Front Pharmacol. 2025;16:1583267. https:\/\/doi.org\/10.3389\/fphar.2025.1583267.","journal-title":"Front Pharmacol"},{"issue":"1","key":"488_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05278-3","volume":"25","author":"S Sadraei","year":"2025","unstructured":"Sadraei S, Aarabi A, Rajai Firouzabadi S, Alinejadfard M, Mohammadi I, Jolfayi AG. Cardiovascular benefits of semaglutide: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2025;25(1):881. https:\/\/doi.org\/10.1186\/s12872-025-05278-3.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"488_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/jcdd11050141","volume":"11","author":"F Natale","year":"2024","unstructured":"Natale F, Luisi E, Franzese R, Mollo N, Solimene A, Caso VM, et al. Semaglutide in cardiometabolic diseases: SELECTing the target population. J Cardiovasc Dev Dis. 2024;11(5):141. https:\/\/doi.org\/10.3390\/jcdd11050141.","journal-title":"J Cardiovasc Dev Dis"},{"key":"488_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2023.100502","volume":"14","author":"ED Michos","year":"2023","unstructured":"Michos ED, Bakris GL, Rodbard HW, Tuttle KR. Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: a review of their kidney and heart protection. Am J Prev Cardiol. 2023;14:100502. https:\/\/doi.org\/10.1016\/j.ajpc.2023.100502.","journal-title":"Am J Prev Cardiol"},{"issue":"12","key":"488_CR49","doi-asserted-by":"publisher","first-page":"14514","DOI":"10.3390\/cimb46120872","volume":"46","author":"I Papakonstantinou","year":"2024","unstructured":"Papakonstantinou I, Tsioufis K, Katsi V. Spotlight on the mechanism of action of semaglutide. Curr Issues Mol Biol. 2024;46(12):14514\u201341. https:\/\/doi.org\/10.3390\/cimb46120872.","journal-title":"Curr Issues Mol Biol"},{"issue":"9","key":"488_CR50","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3390\/jcdd10090394","volume":"10","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Yuan Z, Wang M, Zhang Z, Tan C, Yu J, et al. Liraglutide attenuates aortic valve calcification in a high-cholesterol-diet-induced experimental calcific aortic valve disease model in apolipoprotein E-deficient mice. J Cardiovasc Dev Dis. 2023;10(9):394. https:\/\/doi.org\/10.3390\/jcdd10090394.","journal-title":"J Cardiovasc Dev Dis"},{"key":"488_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.709741","volume":"8","author":"F Xiao","year":"2021","unstructured":"Xiao F, Zha Q, Zhang Q, Wu Q, Chen Z, Yang Y, et al. Decreased glucagon-like peptide-1 is associated with calcific aortic valve disease: GLP-1 suppresses the calcification of aortic valve interstitial cells. Front Cardiovasc Med. 2021;8:709741. https:\/\/doi.org\/10.3389\/fcvm.2021.709741.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"488_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051593","volume":"21","author":"CL Lu","year":"2020","unstructured":"Lu CL, Liao MT, Hou YC, Fang YW, Zheng CM, Liu WC, et al. Sirtuin-1 and its relevance in vascular calcification. Int J Mol Sci. 2020;21(5):1593. https:\/\/doi.org\/10.3390\/ijms21051593.","journal-title":"Int J Mol Sci"},{"key":"488_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1732281","volume":"12","author":"Z Ren","year":"2025","unstructured":"Ren Z, Song B, Peng Y, Bian C, Shen Q, Zhou M, et al. Mechanism and treatment of Sirtuin family in vascular calcification. Front Cardiovasc Med. 2025;12:1732281. https:\/\/doi.org\/10.3389\/fcvm.2025.1732281.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"488_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12060361","volume":"12","author":"M Diaz-Ricart","year":"2020","unstructured":"Diaz-Ricart M, Torramade-Moix S, Pascual G, Palomo M, Moreno-Casta\u00f1o AB, Martinez-Sanchez J, et al. Endothelial damage, inflammation and immunity in chronic kidney disease. Toxins (Basel). 2020;12(6):361. https:\/\/doi.org\/10.3390\/toxins12060361.","journal-title":"Toxins (Basel)"},{"key":"488_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.917773","volume":"13","author":"J Yan","year":"2022","unstructured":"Yan J, Wang J, He JC, Zhong Y. Sirtuin 1 in chronic kidney disease and therapeutic potential of targeting Sirtuin 1. Front Endocrinol (Lausanne). 2022;13:917773. https:\/\/doi.org\/10.3389\/fendo.2022.917773.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"488_CR56","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/eurheartj\/ehae829","volume":"46","author":"MC Blaser","year":"2025","unstructured":"Blaser MC, B\u00e4ck M, L\u00fcscher TF, Aikawa E. Calcific aortic stenosis: omics-based target discovery and therapy development. Eur Heart J. 2025;46(7):620\u201334. https:\/\/doi.org\/10.1093\/eurheartj\/ehae829.","journal-title":"Eur Heart J"},{"issue":"18","key":"488_CR57","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1093\/cvr\/cvaf255","volume":"121","author":"Z Qin","year":"2026","unstructured":"Qin Z, B\u00e4ck M. Advances in single-cell transcriptomics: unraveling the pathogenesis of calcific aortic valve disease. Cardiovasc Res. 2026;121(18):2838\u201359. https:\/\/doi.org\/10.1093\/cvr\/cvaf255.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"488_CR58","doi-asserted-by":"publisher","first-page":"183","DOI":"10.6515\/acs.202005_36(3).20200213a","volume":"36","author":"X Ma","year":"2020","unstructured":"Ma X, Zhao D, Yuan P, Li J, Yun Y, Cui Y, et al. Endothelial-to-mesenchymal transition in calcific aortic valve disease. Acta Cardiol Sin. 2020;36(3):183\u201394. https:\/\/doi.org\/10.6515\/acs.202005_36(3).20200213a.","journal-title":"Acta Cardiol Sin"},{"issue":"1","key":"488_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2015.07.008","volume":"242","author":"J Hjortnaes","year":"2015","unstructured":"Hjortnaes J, Shapero K, Goettsch C, Hutcheson JD, Keegan J, Kluin J, et al. Valvular interstitial cells suppress calcification of valvular endothelial cells. Atherosclerosis. 2015;242(1):251\u201360. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.07.008.","journal-title":"Atherosclerosis"},{"key":"488_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114775","volume":"163","author":"L Shu","year":"2023","unstructured":"Shu L, Yuan Z, Li F, Cai Z. Oxidative stress and valvular endothelial cells in aortic valve calcification. Biomed Pharmacother. 2023;163:114775. https:\/\/doi.org\/10.1016\/j.biopha.2023.114775.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"488_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13377","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu X, Chen A, Liang Q, Yang X, Dong Q, Fu M, et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway. Aging Cell. 2021;20(6):e13377. https:\/\/doi.org\/10.1111\/acel.13377.","journal-title":"Aging Cell"},{"issue":"3","key":"488_CR62","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/cvr\/cvaa134","volume":"117","author":"F Bartoli-Leonard","year":"2021","unstructured":"Bartoli-Leonard F, Wilkinson FL, Schiro A, Serracino Inglott F, Alexander MY, Weston R. Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcification. Cardiovasc Res. 2021;117(3):836\u201349. https:\/\/doi.org\/10.1093\/cvr\/cvaa134.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"488_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37027-2","volume":"9","author":"F Bartoli-Leonard","year":"2019","unstructured":"Bartoli-Leonard F, Wilkinson FL, Schiro A, Inglott FS, Alexander MY, Weston R. Suppression of SIRT1 in diabetic conditions induces osteogenic differentiation of human vascular smooth muscle cells via RUNX2 signalling. Sci Rep. 2019;9(1):878. https:\/\/doi.org\/10.1038\/s41598-018-37027-2.","journal-title":"Sci Rep"},{"issue":"1","key":"488_CR64","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00137.2007","volume":"294","author":"X Meng","year":"2008","unstructured":"Meng X, Ao L, Song Y, Babu A, Yang X, Wang M, et al. Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol. 2008;294(1):C29-35. https:\/\/doi.org\/10.1152\/ajpcell.00137.2007.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"20","key":"488_CR65","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.010025","volume":"7","author":"C Gollmann-Tepek\u00f6yl\u00fc","year":"2018","unstructured":"Gollmann-Tepek\u00f6yl\u00fc C, Lobenwein D, Theurl M, Primessnig U, Lener D, Kirchmair E, et al. Shock wave therapy improves cardiac function in a model of chronic ischemic heart failure: evidence for a mechanism involving VEGF signaling and the extracellular matrix. J Am Heart Assoc. 2018;7(20):e010025. https:\/\/doi.org\/10.1161\/jaha.118.010025.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"488_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00488-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00488-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:28:45Z","timestamp":1783391325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00488-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00488-3","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the North West Multicentre Research Ethics Committee under UKB application number 105945, and Ethics Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (No: [2024]0031 for human, and [2019]1569 for animal). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}